The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth. (Q40385113)
Jump to navigation
Jump to search
scientific article published on September 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth. |
scientific article published on September 2005 |
Statements
The combined treatment of 1,25-dihydroxyvitamin D3 and a non-steroid anti-inflammatory drug is highly effective in suppressing prostate cancer cell line (LNCaP) growth (English)
Michael Steiner
Vladimir Gavrilov